Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 3.170
-0.040 (-1.25%)
At close: Jan 16, 2026
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €249.96 million as of January 16, 2026. Its market cap has increased by 158.90% in one year.
Market Cap
249.96M
Enterprise Value
236.97M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.17
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 249.96M, an increase of 104.89%. That is a compound annual growth rate of 7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 249.96M | 1.93% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.61B |
| Laboratorios Farmaceuticos Rovi | 3.53B |
| Almirall | 2.81B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.38B |
| Clínica Baviera | 829.43M |
| Atrys Health | 232.18M |
| Prim, S.A. | 225.46M |